{
    "title": "EU extends Ozempic review to include more weight-loss, diabetes drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12287767/EU-extends-probe-Ozempic-include-drugs.html",
    "date": "2023-07-11",
    "keywords": [
        "class",
        "drug",
        "agency",
        "weightloss",
        "review",
        "health",
        "regulator",
        "glp1",
        "ema",
        "tuesday",
        "treatment",
        "use",
        "europe",
        "receptor",
        "probe",
        "ozempic",
        "saxenda",
        "july",
        "suicide",
        "case",
        "self",
        "harm",
        "industry",
        "approval",
        "feeling",
        "fullness",
        "drugmaker",
        "trulicity",
        "wegovy",
        "ingredient",
        "semaglutide",
        "part",
        "suliqua",
        "astrazenecas",
        "bydureon",
        "type",
        "safety",
        "ideation",
        "agonist",
        "company",
        "investigation",
        "share",
        "information",
        "comment",
        "risk",
        "cancer",
        "reporting",
        "bhanvi",
        "satija",
        "khushi",
        "mandowara",
        "bengaluru",
        "maggie",
        "fick",
        "editing",
        "maju",
        "samuel",
        "shinjini",
        "ganguli",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}